MT54 Evolving Landscape of Oncology Biosimilars: In-Depth Interview of Stakeholders Regarding Bevacizumab and Trastuzumab Biosimilar
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2762
https://www.valueinhealthjournal.com/article/S1098-3015(23)02952-2/fulltext
Title :
MT54 Evolving Landscape of Oncology Biosimilars: In-Depth Interview of Stakeholders Regarding Bevacizumab and Trastuzumab Biosimilar
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02952-2&doi=10.1016/j.jval.2023.03.2762
First page :
Section Title :
Open access? :
No
Section Order :
11085